Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;46(11):2867-2884.
doi: 10.1007/s11064-021-03366-2. Epub 2021 Jun 1.

Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS

Affiliations

Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS

Elizabeth Minj et al. Neurochem Res. 2021 Nov.

Abstract

Methylmercury (MeHg) is a potent neurotoxin that causes neurotoxicity and neuronal cell death. MeHg exposure also leads to oligodendrocyte destruction, glial cell overactivation, and demyelination of motor neurons in the motor cortex and spinal cord. As a result, MeHg plays an important role in the progression of amyotrophic lateral sclerosis (ALS)-like neurocomplications. ALS is a fatal neurodegenerative disorder in which neuroinflammation is the leading cause of further CNS demyelination. Nuclear factor erythroid-2-related factor-2 (Nrf2)/Heme oxygenase-1 (HO-1) signaling pathway was thought to be a potential target for neuroprotection in ALS. Acetyl-11-keto-beta-boswellic acid (AKBA) is a multi-component pentacyclic triterpenoid mixture derived from Boswellia serrata with anti-inflammatory and antioxidant properties. The research aimed to investigate whether AKBA, as a Nrf2 / HO-1 activator, can provide protection against ALS. Thus, we explored the role of AKBA on the Nrf2/HO-1 signaling pathway in a MeHg-induced experimental ALS model. In this study, ALS was induced in Wistar rats by oral gavage of MeHg 5 mg/kg for 21 days. An open field test, force swim test, and grip strength were performed to observe experimental rats' motor coordination behaviors. In contrast, a morris water maze was performed for learning and memory. Administration of AKBA 50 mg/kg and AKBA 100 mg/kg continued from day 22 to 42. Neurochemical parameters were evaluated in the rat's brain homogenate. In the meantime, post-treatment with AKBA significantly improved behavioral, neurochemical, and gross pathological characteristics in the brain of rats by increasing the amount of Nrf2/HO-1 in brain tissue. Collectively, our findings indicated that AKBA could potentially avoid demyelination and encourage remyelination.

Keywords: AKBA; Amyotrophic lateral sclerosis; Demyelination; Neuroinflammation; Nrf2/HO-1; Oligodendrocytes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hubbard JA, Szu JI, Binder DK (2018) The role of aquaporin-4 in synaptic plasticity memory and disease. Brain Res Bull 136:118–129. https://doi.org/10.1016/j.brainresbull.2017.02.011 - DOI - PubMed
    1. Alam M, Yadav RK, Minj E, Tiwari A, Mehan S (2020) Exploring molecular approaches in Amyotrophic lateral sclerosis: drug targets from clinical and pre-clinical findings. Curr Mol Pharmacol. https://doi.org/10.2174/1566524020666200427214356 - DOI
    1. Gordon PH (2013) Amyotrophic Lateral Sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis 4:295–310 - DOI
    1. Harms MB, Baloh RH (2013) Clinical neurogenetics: amyotrophic lateral sclerosis. Neurol Clin 31:929–950. https://doi.org/10.1016/j.ncl.2013.05.003 - DOI - PubMed
    1. Mhatre M, Floyd RA, Hensley K (2004) Oxidative stress and neuroinflammation in Alzheimer’s disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. J Alzheimer’s Dis 6:147–157. https://doi.org/10.3233/jad-2004-6206 - DOI

MeSH terms

LinkOut - more resources